Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stacy, M.
Right arrow Articles by Jankovic, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stacy, M.
Right arrow Articles by Jankovic, J.
NEUROLOGY 1993;43:937
© 1993 American Academy of Neurology

Tardive stereotypy and other movement disorders in tardive dyskinesias

Mark Stacy, MD, Francisco Cardoso, MD and Joseph Jankovic, MD

Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.

We reviewed the medical records and videotapes of 100 patients with tardive dyskinesia (TD) referred to our movement disorders clinic to characterize the spectrum of hyperkinetic movement disorders caused by dopamine receptor blocking drugs (DRBD). Tardive stereotypy, present in 78 patients, was the most common type of TD, followed by tardive dystonia, akathisia, tremor, chorea, and myoclonus. Sixty-four had a combination of these hyperkinesias. In a second study, a "blind" review of videotapes of patients with a variety of movement disorders found that DRBD were the cause of stereotypic movements in 89.3% of patients, and 96.1% of patients with TD had stereotypy. We conclude that stereotypy can be readily differentiated from other hyperkinetic movement disorders and that its presence in an adult is highly suggestive of prior exposure to DRBD.

Address correspondence and reprint requests to Dr. Joseph Jankovic, Professor of Neurology, Department of Neurology, 6550 Fannin, Suite 1801, Baylor College of Medicine, Houston, TX 77030.

Received June 23, 1992. Accepted for publication in final form September 8, 1992.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E.-K. Tan and J. Jankovic
Tardive and idiopathic oromandibular dystonia: a clinical comparison
J. Neurol. Neurosurg. Psychiatry, February 1, 2000; 68(2): 186 - 190.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J. L Janavs and M. J Aminoff
Dystonia and chorea in acquired systemic disorders
J. Neurol. Neurosurg. Psychiatry, October 1, 1998; 65(4): 436 - 445.
[Full Text]


Home page
J Child NeurolHome page
M. R. Pranzatelli
Topical Review: Antidyskinetic Drug Therapy for Pediatric Movement Disorders
J Child Neurol, September 1, 1996; 11(5): 355 - 369.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by AAN Enterprises, Inc.